Press Releases
Company News
View Summary Medivation Files Preliminary Consent Revocation Statement
May 27, 2016
PDF 24.6 KB Add to Briefcase
View Summary Medivation to Present at the Following Conferences
May 25, 2016
PDF 11.5 KB Add to Briefcase
View Summary Medivation Urges Stockholders to Reject Sanofi's Attempt to Replace Medivation Board of Directors
May 25, 2016
PDF 16.5 KB Add to Briefcase
View Summary Arm of I-SPY 2 TRIAL Investigating Medivation's Talazoparib for Treatment of Breast Cancer Activated
May 23, 2016
PDF 53.0 KB Add to Briefcase
View Summary Medivation Receives Prestigious Award From American Urological Association (AUA)
May 11, 2016
PDF 10.3 KB Add to Briefcase
View Summary Medivation Reports First Quarter 2016 Financial Results
May 5, 2016
PDF 100.5 KB Add to Briefcase
View Summary Medivation Reiterates Rejection of Sanofi's Substantially Inadequate Proposal
May 5, 2016
PDF 18.1 KB Add to Briefcase
View Summary Medivation Announces First Quarter 2016 Financial Results Teleconference on May 5, 2016
May 3, 2016
PDF 11.3 KB Add to Briefcase
View Summary Medivation's Board of Directors Unanimously Rejects Sanofi's Unsolicited Proposal
Apr 29, 2016
PDF 23.1 KB Add to Briefcase
View Summary Medivation Confirms Receipt of Unsolicited Proposal From Sanofi
Apr 28, 2016
PDF 11.0 KB Add to Briefcase
View Summary Medivation Announces Participation at Upcoming Investor Conferences
Apr 27, 2016
PDF 11.2 KB Add to Briefcase
View Summary Medivation Announces First Quarter 2016 Financial Results Teleconference on May 5, 2016
Apr 21, 2016
PDF 9.0 KB Add to Briefcase
View Summary Medivation Announces Presentation of Phase 2 Enzalutamide Data Evaluating Potential Immune-Activating Properties in Non-Metastatic Castration Sensitive Prostate Cancer Patients
Apr 20, 2016
PDF 69.7 KB Add to Briefcase
View Summary Medivation Announces Presentation of Phase I Talazoparib Combination Data in Several Advanced Cancers
Apr 17, 2016
PDF 67.6 KB Add to Briefcase
View Summary CHMP Issues Positive Opinion to Include New Data in European Label for XTANDI(R) (Enzalutamide)
Apr 7, 2016
PDF 69.8 KB Add to Briefcase
View Summary Jennifer Jarrett to Join Medivation as Chief Financial Officer
Mar 28, 2016
PDF 12.8 KB Add to Briefcase
View Summary Pivotal Phase III Trial of Enzalutamide Initiated in Metastatic Hormone Sensitive Prostate Cancer
Mar 24, 2016
PDF 338.0 KB Add to Briefcase
View Summary U.S. FDA Lifts Partial Clinical Hold on Medivation's Pidilizumab
Mar 9, 2016
PDF 12.0 KB Add to Briefcase
View Summary Medivation to Present at Barclays Global Healthcare Conference
Mar 1, 2016
PDF 9.2 KB Add to Briefcase
View Summary Medivation Reports Fourth Quarter and Full Year 2015 Financial Results and Provides 2016 Financial Guidance
Feb 25, 2016
PDF 103.6 KB Add to Briefcase
Showing 1-20 of 373 Page: 1 2 3 4 5 ... 19  Next 20
Add to Briefcase = add release to Briefcase

Top